Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 58 Records) |
| Query Trace: Ovarian Neoplasms and BARD1[original query] |
|---|
| Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients. Clinical biochemistry 2019 Nov . Rodríguez-Balada Marta, Roig Bàrbara, Melé Mireia, Albacar Cinta, Serrano Sara, Salvat Mònica, Querol Montserrat, Borràs Joan, Martorell Lourdes, Gumà Jos |
| Germline Genetic Findings Which May Impact Therapeutic Decisions in Families with a Presumed Predisposition for Hereditary Breast and Ovarian Cancer. Cancers 2020 8 12 (8): . Velázquez Carolina, K De Leeneer, Esteban-Cardeñosa Eva M, Avila Cobos Francisco, Lastra Enrique, Abella Luis E, de la Cruz Virginia, Lobatón Carmen D, Claes Kathleen B, Durán Mercedes, Infante M |
| Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers. Genes 2020 7 11 (8): . Alenezi Wejdan M, Fierheller Caitlin T, Recio Neil, Tonin Patricia |
| Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations. Genes 2020 7 11 (7): . Suszynska Malwina, Kozlowski Pio |
| Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome. NPJ breast cancer 2020 6 6 25. Kaneyasu Tomoko, Mori Seiichi, Yamauchi Hideko, Ohsumi Shozo, Ohno Shinji, Aoki Daisuke, Baba Shinichi, Kawano Junko, Miki Yoshio, Matsumoto Naomichi, Nagasaki Masao, Yoshida Reiko, Akashi-Tanaka Sadako, Iwase Takuji, Kitagawa Dai, Masuda Kenta, Hirasawa Akira, Arai Masami, Takei Junko, Ide Yoshimi, Gotoh Osamu, Yaguchi Noriko, Nishi Mitsuyo, Kaneko Keika, Matsuyama Yumi, Okawa Megumi, Suzuki Misato, Nezu Aya, Yokoyama Shiro, Amino Sayuri, Inuzuka Mayuko, Noda Tetsuo, Nakamura Sei |
| Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer. Cancers 2020 4 12 (4): . Lhotova Klara, Stolarova Lenka, Zemankova Petra, Vocka Michal, Janatova Marketa, Borecka Marianna, Cerna Marta, Jelinkova Sandra, Kral Jan, Volkova Zuzana, Urbanova Marketa, Kleiblova Petra, Machackova Eva, Foretova Lenka, Hazova Jana, Vasickova Petra, Lhota Filip, Koudova Monika, Cerna Leona, Tavandzis Spiros, Indrakova Jana, Hruskova Lucie, Kosarova Marcela, Vrtel Radek, Stranecky Viktor, Kmoch Stanislav, Zikan Michal, Macurek Libor, Kleibl Zdenek, Soukupova Ja |
| The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort. Journal of the National Cancer Institute 2020 Feb . Hu Chunling, Polley Eric C, Yadav Siddhartha, Lilyquist Jenna, Shimelis Hermela, Na Jie, Hart Steven N, Goldgar David E, Shah Swati, Pesaran Tina, Dolinsky Jill S, LaDuca Holly, Couch Fergus |
| Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC medical genomics 2020 Feb 13 (1): 21. da Costa E Silva Carvalho Simone, Cury Nathalia Moreno, Brotto Danielle Barbosa, de Araujo Luiza Ferreira, Rosa Reginaldo Cruz Alves, Texeira Lorena Alves, Plaça Jessica Rodrigues, Marques Adriana Aparecida, Peronni Kamila Chagas, Ruy Patricia de Cássia, Molfetta Greice Andreotti, Moriguti Julio Cesar, Carraro Dirce Maria, Palmero Edenir Inêz, Ashton-Prolla Patricia, de Faria Ferraz Victor Evangelista, Silva Wilson Arau |
| Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition. Genes, chromosomes & cancer 2020 Oct . Cavaillé Mathias, Uhrhammer Nancy, Privat Maud, Ponelle-Chachuat Flora, Gay-Bellile Mathilde, Lepage Mathis, Molnar Ioana, Viala Sandrine, Bidet Yannick, Bignon Yves-Je |
| Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens. International journal of cancer 2021 9 150 (2): 279-289. Quintanilha Julia C F, Wang Jin, Sibley Alexander B, Xu Wei, Espin-Garcia Osvaldo, Jiang Chen, Etheridge Amy S, Ratain Mark J, Lenz Heinz-Josef, Bertagnolli Monica, Kindler Hedy L, Dickler Maura N, Venook Alan, Liu Geoffrey, Owzar Kouros, Lin Danyu, Innocenti Federi |
| A synergetic effect of BARD1 mutations on tumorigenesis. Nature communications 2021 2 12 (1): 1243. Li Wenjing, Gu Xiaoyang, Liu Chunhong, Shi Yanyan, Wang Pan, Zhang Na, Wu Rui, Leng Liang, Xie Bingteng, Song Chen, Li |
| Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools. Cancer prevention research (Philadelphia, Pa.) 2021 12 15 (3): 151-160. Suszynska Malwina, Ratajska Magdalena, Galka-Marciniak Paulina, Ryszkowska Aleksandra, Wydra Dariusz, Debniak Jaroslaw, Jasiak Anna, Wasag Bartosz, Cybulski Cezary, Kozlowski Pio |
| RNA assay identifies a previous misclassification of BARD1 c.1977A>G variant. Scientific reports 2021 11 11 (1): 22948. Rofes Paula, Pineda Marta, Feliubadaló Lídia, Menéndez Mireia, de Cid Rafael, Gómez Carolina, Montes Eva, Capellá Gabriel, Brunet Joan, Del Valle Jesús, Lázaro Con |
| Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing. Cancers 2021 10 13 (20): . Wessman Sandra, Fuentes Beatriz Bohorquez, Törngren Therese, Kvist Anders, Kokaraki Georgia, Menkens Hanna, Hjerpe Elisabet, Hugo Ythalo, Petta Tirzah Braz, Borg Åke, Carlson Joseph |
| Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients with Familial Breast and Ovarian Cancer. Cancers 2021 Jan 13 (1): . Lepkes Louisa, Kayali Mohamad, Blümcke Britta, Weber Jonas, Suszynska Malwina, Schmidt Sandra, Borde Julika, Klonowska Katarzyna, Wappenschmidt Barbara, Hauke Jan, Kozlowski Piotr, Schmutzler Rita K, Hahnen Eric, Ernst Corin |
| BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort. Genes 2021 1 12 (2): . Rofes Paula, Del Valle Jesús, Torres-Esquius Sara, Feliubadaló Lídia, Stradella Agostina, Moreno-Cabrera José Marcos, López-Doriga Adriana, Munté Elisabet, De Cid Rafael, Campos Olga, Cuesta Raquel, Teulé Álex, Grau Èlia, Sanz Judit, Capellá Gabriel, Díez Orland, Brunet Joan, Balmaña Judith, Lázaro Con |
| Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants. Scientific reports 2022 May 12 (1): 8547. Benito-Sánchez B, Barroso A, Fernández V, Mercadillo F, Núñez-Torres R, Pita G, Pombo L, Morales-Chamorro R, Cano-Cano J M, Urioste M, González-Neira A, Osorio |
| Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women. JCO precision oncology 2022 2 1 1-12. Kurian Allison W, Hughes Elisha, Handorf Elizabeth A, Gutin Alexander, Allen Brian, Hartman Anne-Renee, Hall Michael |
| Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. Journal of the National Cancer Institute 2022 10 115 (2): 181-189. Lim Belle W X, Li Na, Mahale Sakshi, McInerny Simone, Zethoven Magnus, Rowley Simone M, Huynh Joanne, Wang Theresa, Lee Jue Er Amanda, Friedman Mia, Devereux Lisa, Scott Rodney J, Sloan Erica K, James Paul A, Campbell Ian |
| Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees. Journal of medical genetics 2023 9 . Mathias Schwartz, Sabrina Ibadioune, Albain Chansavang, Sophie Vacher, Sandrine M Caputo, Hélène Delhomelle, Jennifer Wong, Khadija Abidallah, Virginie Moncoutier, Véronique Becette, Tatiana Popova, Voreak Suybeng, Antoine De Pauw, Marc-Henri Stern, Chrystelle Colas, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Lisa Golmard, Ivan Bieche, Julien Masliah-Planch |
| Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer. JCO precision oncology 2023 8 7 e2200695. Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Edward D Esplin, Anneke Lucassen, Nadine M Tung, Claudine Isaa |
| Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes. Scientific reports 2023 5 13 (1): 8536. Nanna Bæk Møller, Desirée Sofie Boonen, Elisabeth Simone Feldner, Qin Hao, Martin Larsen, Anne-Vibeke Lænkholm, Åke Borg, Anders Kvist, Therese Törngren, Uffe Birk Jensen, Susanne Eriksen Boonen, Mads Thomassen, Thorkild Terkels |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
| Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. Asian Pacific journal of cancer prevention : APJCP 2023 2 24 (2): 525-530. Sukpan Panupong, Kanokwiroon Kanyanatt, Sriplung Hutcha, Laochareonsuk Wison, Choochuen Pongsakorn, Auseng Nasuha, Wanawanakorn Kasemsun, Sangkhathat Suras |
| Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers. Gynecologic oncology 2023 2 170 234-240. Lee Sarah S, Karpel Hannah C, Oh Cheongeun, Smith Julia, Pothuri Bhava |
| Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. Gynecologic oncology 2023 12 180 35-43. Ryan M Kahn, Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Y Sia, Anna Maio, Yelena Kemel, Margaret Sheehan, Erin Salo-Mullen, Kelsey E Breen, Qin Zhou, Alexia Iasonos, Rachel N Grisham, Roisin E O'Cearbhaill, Dennis S Chi, Michael F Berger, Ritika Kundra, Nikolaus Schultz, Lora H Ellenson, Zsofia K Stadler, Kenneth Offit, Diana Mandelker, Carol Aghajanian, Dmitriy Zamarin, Paul Sabbatini, Britta Weigelt, Ying L L |
| Universal Genetic Testing for Newly Diagnosed Invasive Breast Cancer. JAMA network open 2024 9 7 (9): e2431427. Zoulikha Rezoug, Stephanie P Totten, David Szlachtycz, Adrienne Atayan, Kristen Mohler, Sophie Albert, Leila Feng, Brianna Lemieux Anglin, Zhen Shen, Daniel Jimenez, Nancy Hamel, Nicholas Meti, Khashayar Esfahani, Jean-François Boileau, Ipshita Prakash, Mark Basik, Sarkis Meterissian, Francine Tremblay, David Fleiszer, Dawn Anderson, George Chong, Stephanie M Wong, William D Foulk |
| Identification of ubiquitin markers for survival and prognosis of ovarian cancer. Heliyon 2024 9 10 (18): e37288. Yiwen Feng, Liyun Shan, Yanping Gong, Wenzhao Hang, Zhenyu Sang, Yunyan Sun, Kefu Tang, Yulan Wang, Binjie Hu, Xiaowei |
| Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background. International journal of molecular sciences 2024 12 25 (23): . Petra Nagy, János Papp, Vince Kornél Grolmusz, Anikó Bozsik, Tímea Pócza, Edit Oláh, Attila Patócs, Henriett Bu |
| Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers. Revista da Associacao Medica Brasileira (1992) 2024 10 70 (10): e20240534. Ferah Kazanci, Zerrin Y?lmaz Çelik, Mert Polat, Ferhat Karademir, Ozlem Erdem, Feride ?ffet ?ahin, Mehmet Anil On |
- Page last reviewed:Feb 1, 2024
- Content source: